Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price5.00 USD
Ethical score30.0/100
RatingAVOID
Our investment reviews on this name
2026-10-29Read Markup5.00+0.0% to today ✓Distribution gives way to Markup after a 9% slide in 11 days
2026-10-18Read Distribution5.52-9.4% to today ✓Markup gives way to Distribution first Distribution read since October
2026-10-11Read Markup5.68-11.9% to today Distribution gives way to Markup first Markup read since September
2026-10-02Read Distribution5.68-11.9% to today ✓Markup gives way to Distribution after a 19% rise in 6 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Aozora Bank, Ltd. holds its Markup at $5.00. Consolidating, no directional conviction, held for 1 days.
As held on the ledger · 2026-10-27
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 1 days
Price at the screen
$5.00
Valuation
13.89 trailing · N/A forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.22
The Workings
Five Screens, Shown in Full
Does not pass. Business activity
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Financial sector: banks
Fail
Debt load
0.00%
Below 33%
Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
129.66%
Below 5%
129.7% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Aozora Bank, does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when AOZOY's ethical verdict changes
Today AOZOY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it gives us pause
On our numbers, the price already runs ahead of the business.
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AOZOY trades on PNK (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Markup · changed$5.00-9.4%Entry 11
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 9.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a moderate risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-10-11Markup · changed$5.68+0.0%Entry 9
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-10-02Distribution · changed$5.68+6.2%Entry 8
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-09-21Markup$5.35+12.5%Entry 7
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-08-21Markup · changed$4.75+26.7%Entry 6
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 26.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-07-21Accumulation$3.75-5.1%Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-07-18Accumulation$3.95+0.0%Entry 4
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-07-17Accumulation$3.95+0.0%Entry 3
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
2026-07-03Accumulation$3.95+0.0%Entry 2
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.